Navigation Links
HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
Date:5/16/2013

FRAMINGHAM, Mass. and SYDNEY, May 16, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, May 20, 2013.  The conference is being held May 20-22, 2013 at the Sheraton New York Hotel.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 30 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864

 


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. Heartware Schedules First Quarter Conference Call And Webcast
3. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
4. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
5. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. HeartWare Schedules Second Quarter Conference Call And Webcast
8. HeartWare Completes Acquisition Of World Heart Corporation
9. HeartWare Reports Second Quarter 2012 Results
10. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
11. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2019)... (PRWEB) , ... August 17, 2019 , ... ... Companies—the Inc. 5000 , Foster Crown, LLC Ranks No. 2502 on the 2019 ... revealed that Foster Crown, LLC, the boutique physician recruitment firm is No. 2502 ...
(Date:8/16/2019)... ... August 16, 2019 , ... Healthpointe is proud to announce ... (EMDR). This therapeutic technique aims to reduce psychological distress, promote healing, and strengthen ... (PTSD), depression, chronic pain, anxiety, and grief. EMDR is applicable for a ...
(Date:8/16/2019)... ... 2019 , ... The American Academy of Emergency Medicine Physician ... as a member group. , SBEP is a longstanding democratic group that has ... out the AAEM-PG for administrative and practice management support that will help preserve ...
Breaking Medicine Technology:
(Date:8/21/2019)... ... 2019 , ... Alsana , an integrative and data-driven ... 2020. Alsana will offer an eating disorder treatment program for adults 18+ with ... program will provide a continuum of care as clients progress through the stages ...
(Date:8/21/2019)... ANTONIO (PRWEB) , ... August 21, 2019 , ... Photoprotective ... skin care products. This water-based ingredient is currently used in skincare products such as ... PPT. The award-winning product addresses the growing need to protect the skin from blue ...
(Date:8/21/2019)... Calif. (PRWEB) , ... August ... ... to announce a revolutionary advancement in automated x-ray inspection technology: HDRX imaging. ... and minimized false rejects. More importantly, HDRX can deliver high image resolution ...
(Date:8/19/2019)... ... August 19, 2019 , ... AJG Packaging, ... announced the availability of resealable single-dose vials for a multitude of applications. The ... consists of five resealable breakaway vials and are available in either polyethylene or ...
(Date:8/19/2019)... ... August 19, 2019 , ... American Society for ... cosmetic procedures in 2018 – 7.5 percent more than 2017 and a 60 ... Survey on Dermatologic Procedures revealed skin cancer treatments are persistently the ...
Breaking Medicine News(10 mins):